Wednesday, March 13, 2024

🌎 Tesla Downgraded, Legend Biotech Initiated, Carnival Co. & Initiated and more...

Ratings changes for Jaguar Health, Tesla, Vertex Pharmaceuticals, Cue Biopharma, Legend Biotech, Peoples Bancorp, Immunovant and more...Upgrade to MarketBeat All Access to get early delivery, personalized stock alerts, portfolio monitoring tools, and more. Start Your Free Trial.
March 13th, 2024
S and P pricesDow pricesQQQ prices
Follow MarketBeat on Twitter Join the MarketBeat Facebook Group Subscribe on YouTube 


Your Watchlist (Manage Your Watchlist and Monitor Your Portfolio)

Analysts' Upgrades
  • BILL (NYSE:BILL) was upgraded by analysts at BNP Paribas from an "underperform" rating to a "neutral" rating. They now have a $72.00 price target on the stock. This represents a 5.7% upside from the current price of $68.12.
  • Kanzhun (NASDAQ:BZ) was upgraded by analysts at New Street Research from a "neutral" rating to a "buy" rating. They now have a $25.00 price target on the stock, up previously from $17.00. This represents a 20.4% upside from the current price of $20.76.
  • Cellebrite DI (NASDAQ:CLBT) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.The current price is $11.82.
  • Cooper Companies (NASDAQ:COO) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $120.00 price target on the stock, up previously from $100.00. This represents a 16.7% upside from the current price of $102.86.
  • Evergy (NYSE:EVRG) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $57.00 price target on the stock, up previously from $51.00. This represents a 9.8% upside from the current price of $51.91.
  • Koppers (NYSE:KOP) was upgraded by analysts at Singular Research from a "hold" rating to a "buy" rating. They now have a $67.50 price target on the stock. This represents a 25.1% upside from the current price of $53.95.
  • Southwest Airlines (NYSE:LUV) was upgraded by analysts at Jefferies Financial Group Inc. from an "underperform" rating to a "hold" rating. They now have a $28.00 price target on the stock, up previously from $20.00. This represents a 2.7% downside from the current price of $28.78.
  • Moelis & Company (NYSE:MC) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "sell" rating to a "neutral" rating. They now have a $58.00 price target on the stock, up previously from $53.00. This represents a 6.0% upside from the current price of $54.72.
  • NICE (NASDAQ:NICE) was upgraded by analysts at DA Davidson from a "neutral" rating to a "buy" rating. They now have a $300.00 price target on the stock, up previously from $250.00. This represents a 24.1% upside from the current price of $241.66.
  • Nucor (NYSE:NUE) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $240.00 price target on the stock, up previously from $180.00. This represents a 30.4% upside from the current price of $184.06.
  • Purple Innovation (NASDAQ:PRPL) was upgraded by analysts at Roth Mkm from a "neutral" rating to a "buy" rating. They now have a $2.50 price target on the stock, up previously from $2.00. This represents a 44.5% upside from the current price of $1.73.
  • Tri Pointe Homes (NYSE:TPH) was upgraded by analysts at Royal Bank of Canada from a "sector perform" rating to an "outperform" rating. They now have a $38.00 price target on the stock. This represents a 8.1% upside from the current price of $35.16.
  • Texas Roadhouse (NASDAQ:TXRH) was upgraded by analysts at Robert W. Baird from a "neutral" rating to an "outperform" rating. They now have a $175.00 price target on the stock, up previously from $160.00. This represents a 13.1% upside from the current price of $154.70.
  • View today's most recent analysts' upgrades at MarketBeat.com right arrow


Analysts' Downgrades
  • Grupo Aeroportuario del Sureste, S. A. B. de C. V. (NYSE:ASR) was downgraded by analysts at Barclays PLC from an "overweight" rating to an "equal weight" rating.The current price is $300.91.
  • Brown & Brown (NYSE:BRO) was downgraded by analysts at Bank of America Co. from a "neutral" rating to an "underperform" rating. They now have a $86.00 price target on the stock, up previously from $80.00. This represents a 1.1% upside from the current price of $85.06.
  • Cleveland-Cliffs (NYSE:CLF) was downgraded by analysts at Citigroup Inc. from a "buy" rating to a "neutral" rating. They now have a $22.00 price target on the stock. This represents a 9.0% upside from the current price of $20.19.
  • EQT (NYSE:EQT) was downgraded by analysts at Mizuho from a "buy" rating to a "neutral" rating. They now have a $39.00 price target on the stock, down previously from $46.00. This represents a 13.2% upside from the current price of $34.46.
  • Fidelity National Information Services (NYSE:FIS) was downgraded by analysts at Robert W. Baird from an "outperform" rating to a "neutral" rating. They now have a $78.00 price target on the stock, up previously from $76.00. This represents a 11.8% upside from the current price of $69.76.
  • Humana (NYSE:HUM) was downgraded by analysts at Argus from a "buy" rating to a "hold" rating.The current price is $349.16.
  • InterContinental Hotels Group (NYSE:IHG) was downgraded by analysts at Jefferies Financial Group Inc. from a "buy" rating to a "hold" rating.The current price is $106.74.
  • InterContinental Hotels Group (NYSE:IHG) was downgraded by analysts at Sanford C. Bernstein from a "market perform" rating to an "underperform" rating.The current price is $106.74.
  • MP Materials (NYSE:MP) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. They now have a $15.50 price target on the stock, down previously from $26.00. This represents a 6.7% upside from the current price of $14.53.
  • Sibanye Stillwater (NYSE:SBSW) was downgraded by analysts at Jefferies Financial Group Inc. from a "buy" rating to a "sell" rating.The current price is $4.72.
  • SurgePays (NASDAQ:SURG) was downgraded by analysts at Maxim Group from a "buy" rating to a "hold" rating.The current price is $5.23.
  • Latham Group (NASDAQ:SWIM) was downgraded by analysts at Bank of America Co. from a "buy" rating to an "underperform" rating. They now have a $2.60 price target on the stock, down previously from $4.50. This represents a 14.8% downside from the current price of $3.05.
  • View today's most recent analysts' downgrades at MarketBeat.com right arrow


Analysts' New Coverage
  • Axon Enterprise (NASDAQ:AXON) is now covered by analysts at Argus. They set a "buy" rating and a $380.00 price target on the stock. This represents a 23.4% upside from the current price of $308.01.
  • Bitdeer Technologies Group (NASDAQ:BTDR) is now covered by analysts at BTIG Research. They set a "buy" rating and a $15.00 price target on the stock. This represents a 125.9% upside from the current price of $6.64.
  • Carnival Co. & (NYSE:CCL) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $20.00 price target on the stock. This represents a 19.3% upside from the current price of $16.77.
  • Campbell Soup (NYSE:CPB) is now covered by analysts at Evercore ISI. They set an "in-line" rating and a $49.00 price target on the stock. This represents a 14.5% upside from the current price of $42.80.
  • Cue Biopharma (NASDAQ:CUE) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $6.00 price target on the stock. This represents a 180.3% upside from the current price of $2.14.
  • Fulcrum Therapeutics (NASDAQ:FULC) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $14.00 price target on the stock. This represents a 19.0% upside from the current price of $11.76.
  • IDACORP (NYSE:IDA) is now covered by analysts at Morgan Stanley. They set an "equal weight" rating and a $92.00 price target on the stock. This represents a 1.0% upside from the current price of $91.10.
  • Immunovant (NASDAQ:IMVT) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $50.00 price target on the stock. This represents a 62.2% upside from the current price of $30.83.
  • Legend Biotech (NASDAQ:LEGN) is now covered by analysts at Raymond James. They set an "outperform" rating and a $86.00 price target on the stock. This represents a 25.1% upside from the current price of $68.72.
  • Manhattan Associates (NASDAQ:MANH) is now covered by analysts at Citigroup Inc.. They set a "neutral" rating and a $260.00 price target on the stock. This represents a 2.6% upside from the current price of $253.43.
  • MidWestOne Financial Group (NASDAQ:MOFG) is now covered by analysts at Piper Sandler. They set a "neutral" rating and a $24.00 price target on the stock. This represents a 6.1% upside from the current price of $22.62.
  • Norwegian Cruise Line (NYSE:NCLH) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $19.00 price target on the stock. This represents a 3.8% downside from the current price of $19.75.
  • Prelude Therapeutics (NASDAQ:PRLD) is now covered by analysts at JMP Securities. They set a "mkt outperform" rating and a $7.00 price target on the stock. This represents a 62.8% upside from the current price of $4.30.
  • Royal Caribbean Cruises (NYSE:RCL) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $162.00 price target on the stock. This represents a 22.3% upside from the current price of $132.49.
  • SPS Commerce (NASDAQ:SPSC) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $216.00 price target on the stock. This represents a 18.3% upside from the current price of $182.56.
  • View today's most recent analysts' new coverage at MarketBeat.com right arrow

Upgrade Your Subscription
Manage Your Watchlist
Join Our Facebook Group

Thank you for subscribing to MarketBeat!
We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.
 
If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.
 
© 2006-2024 MarketBeat Media, LLC.
345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States.
 
Today's Bonus Content: Will Crypto Make People Rich Again Starting April, 2024?

No comments:

Post a Comment

Our Latest Breakthrough – A Seasonality System for Growing Profits, Year After Year

We've cracked the code to identify the market's repeating cycles. And now we're putting that power in your hands.   ...